Elizabeth Arden, Inc. (RDEN)
The Company is a manufacturer, marketer and designer of fragrances, skin treatment and cosmetic products, to customers in the United States and internationally.
Recs
This account tracks the performance of newly minted 4 star stocks - 3 star stocks that recently turned in to 4 star stocks.
Recs
Considering Book value, earnings, and market cap...this should beat the market in 5 years.
Recs
PureValue, not so sure about this one because of debt. On the other hand they might be able to make a profit even on considerably reduced sales. Might allow them to go throw the depression and come out as a winner.
Recs
There is a bullish story to this stock - lipstick sales go up during a depression/recession. but its PE is way too high, too much debt, Revenue is increasing but net income is negative and decreasing. What seems to me like a classic - "We lose 3 cents on each unit but we make it up in volume" story.
Recs
38% dip..will atleast expect it to go 5-10% north in coming weeks
Recs
The type of stock helps me to believe that this will outperform it's competitors.
Recs
The stock still has solid fundamentals and a strong customer base. I think it is oversold and a good buy at this price.
Recs
Low PEG. Stock will rise to the market.
Recs
They've had a bad year, and have been beaten up by acquisition troubles. I think they're ready for new heights.
Recs
Smell a rat on Elizabeth Arden. It is an US based beauty products company engaged in the manufacturing and marketing of fragrances, skin care products and cosmetic products worldwide. In addition to over 100 owned and licensed prestige brands, the company also distributes over 200 additional prestige fragrance brands principally to mass retailers in the United States. Fragrances contribute around 75% of the sales followed by skincare and cosmetics.
The life cycle of fragrances has shortened dramatically in recent years. Loyalty towards the brand is declining and more and more customers are experimenting with different brands within a short span. Hence, companies are launching new products at a very faster rate to meet the market demand. To face the industry challenges, Elizabeth Arden has been incurring huge marketing spends and undergoing promotional activities, which is finally grinding down the bottom lines of the company. The company did generate about 12% rise in revenues in the first quarter of fiscal 2007 driven by sale of new brands and acquisitions of Riviera and Sovereign. However, revenues are rising at the cost of spiraling expenses. In the past two quarters, the company financials has gone in the red and costs are likely to rise ahead on account of marketing expenses and acquisition related integration costs.
Conversely, management is upbeat on their ‘Prevage’ skin care line as demand for anti-aging products is rising. However on the negative side, revenues could take a hit due to Wal-Mart’s shift in the product mix, as Elizabeth Arden currently derives significant revenues from Wal-Mart. Also, it is expecting the benefit of acquisitions to materialize later in 2008. Considering these facts, the scrip does not look an exciting investment from one-year perspective.
Recs
Undervalued take-over candidate
Recs
Price is right to buy. Holiday season should boost sales of beauty products and I like the company's management.
Recs
Elizabeth Arden is the way to go for beauty. They're dominating the fragrance market, and slowly taking over the creams/cosmetics markets also. Their wide range of products appeal to any demographic, and who can really say no to a face like Catherine Zeta-Jones?

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 13 of 13